Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Institutes of Health Clinical Center (CC)
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
St. Jude Children's Research Hospital
Universität des Saarlandes
Universität des Saarlandes
Universität des Saarlandes
M.D. Anderson Cancer Center
Acrotech Biopharma Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
St. Jude Children's Research Hospital
Polish Lymphoma Research Group
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
AIDS Malignancy Consortium
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
Centre Henri Becquerel
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
SWOG Cancer Research Network
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Johann Wolfgang Goethe University Hospital